These are exciting times in pediatric neuro-oncology research, and nowhere is that excitement felt more than right here in the CBTP labs. We have recently doubled in size, thanks to the generous support of our families and friends. Where once our two teams worked side by side, taking parallel paths toward our common goal, now we are four. And we couldn’t be happier about that.
This spring we were honored to welcome Nadia Dahmane, Ph.D., to our team. Dr. Dahmane joined us from the University of Pennsylvania, where she ran an NIH-funded laboratory focused on fetal developmental biology. Her expertise in cell proliferation and differentiation—and how those processes can go wrong and lead to the development of a tumor—is the perfect complement to our work. We have learned that one of the best ways to defeat a disease process is to understand how it begins, then “reverse engineer” that process in an effort to find a way to stop it. We are delighted to have Dr. Dahmane on board, along with Dr. Chaomei Xiang, who will be working alongside her on these important projects.
We are equally excited to welcome Babacar Cisse, M.D., Ph.D., to the CBTP. Until June, Dr. Cisse was Chief Resident in Neurological Surgery here at Weill Cornell Medicine. Upon completion of his residency, Dr. Cisse accepted our offer to join the faculty—and the CBTP.
Dr. Cisse has been working closely with Dr. Greenfield’s lab for the past several years, specifically on research into the progression of low-grade gliomas into high-grade malignancies. We are so glad to have him join our laboratory to enhance our investigations into those processes.
This newsletter includes a summary of the new findings and projects your generosity has funded. With a lab full of new investigators and interns, we are confident that our pace will increase and our progress will quicken. We are so glad to have you all behind us on this mission.